ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
Sandoz Group AG
45.95
+1.03
2.30%
成交量:
7,595.00
成交额:
34.70万
市值:
198.05亿
市盈率:
-2,470.27
高:
46.06
开:
45.62
低:
45.62
收:
44.92
数据加载中...
总览
公司
新闻
公告
复宏汉霖与山德士就伊匹木单抗生物类似药达成授权合作,总金额超3亿美元
美通社
·
04-29
Sandoz集团公布2024财年净销售额为103.6亿美元,低于预期的104.1亿美元,每股收益为2.71美元
财报速递
·
03-05
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/SDZNY/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SDZNY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SDZNY\",,,,,undefined,":{"symbol":"SDZNY","market":"US","secType":"STK","nameCN":"Sandoz Group AG","latestPrice":45.952,"timestamp":1747324440000,"preClose":44.92,"halted":0,"volume":7595,"delay":15,"floatShares":399980000,"shares":431000000,"eps":-0.018602,"marketStatus":"交易中","change":1.032,"latestTime":"05-15 11:54:00 EDT 延时","open":45.6201,"high":46.0599,"low":45.62,"amount":346989.1194,"amplitude":0.009793,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.018602,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1747339200000},"marketStatusCode":2,"adr":0,"adrRate":1,"exchange":"OTCQX","adjPreClose":44.92,"volumeRatio":0.725553},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SDZNY\",,,,,undefined,":{"symbol":"SDZNY","floatShares":399980000,"roa":"0.98%","roe":"0.01%","lyrEps":0.179111,"volumeRatio":0.725553,"shares":431000000,"dividePrice":0.66212,"high":46.0599,"amplitude":0.009793,"preClose":44.92,"low":45.62,"week52Low":34.5,"pbRate":"2.43","psRate":"1.91","week52High":49.8099,"institutionHeld":0,"latestPrice":45.952,"eps":-0.018602,"divideRate":0.014409,"volume":7595,"delay":15,"ttmEps":-0.018602,"open":45.6201,"prevYearClose":40.5,"prevWeekClose":45.66,"prevMonthClose":43.38,"prevQuarterClose":41.92,"fiveDayClose":44.9,"twentyDayClose":40.1,"sixtyDayClose":46.8},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SDZNY\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531605177","title":"复宏汉霖与山德士就伊匹木单抗生物类似药达成授权合作,总金额超3亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531605177","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531605177?lang=zh_cn&edition=fundamental","pubTime":"2025-04-29 23:38","pubTimestamp":1745941080,"startTime":"0","endTime":"0","summary":"根据协议条款,复宏汉霖将负责HLX13的研发、生产以及商业化供应,并从交易中获得3.01亿美元的潜在收入,其中3100万美元为交易首付款。作为全球仿制药与生物类似药领域的领导者,山德士始终以\"让健康触手可及\"为使命,凭借约1,300款产品累计惠及全球9亿患者。此次复宏汉霖携手山德士,将充分借力其成熟的全球网络与生物类似药商业化优势,加速HLX13在全球主流生物药市场的可及性。此次与山德士的合作,将进一步提升公司产品的全球可及性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4675725_ZH75725_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4007","SDZNY","BK1161","02696"],"gpt_icon":0},{"id":"1111075095","title":"Sandoz集团公布2024财年净销售额为103.6亿美元,低于预期的104.1亿美元,每股收益为2.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111075095","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111075095?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 16:01","pubTimestamp":1741161697,"startTime":"0","endTime":"0","summary":"Sandoz集团公布2024财年净销售额为103.6亿美元,低于预期的104.1亿美元,调整后每股收益为2.71美元。以上内容来自Benzinga Earnings专栏,原文如下:Sandoz Group AG Reported FY24 Net Sales Of $10.36B Vs $10.41B Est, Adj EPS Of $2.71","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AG","SDZNY"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SDZNY\",params:#limit:5,,,undefined,":[{"date":"2025-04-22","symbol":"SDZNY","amount":0.67446,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-22","defaultRemindTime":1745328600000,"name":"Sandoz Group AG","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-23","payableDate":"2025-04-22","currency":"USD","dateTimestamp":1745294400000,"payDate":"2025-04-23"},{"date":"2024-05-03","symbol":"SDZNY","amount":0.4983609,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-05-06","defaultRemindTime":1714743000000,"name":"Sandoz Group AG","recordDate":"2024-05-07","payableDate":"2024-05-06","currency":"USD","dateTimestamp":1714708800000,"payDate":"2024-05-07"},{"market":"US","date":"2024-03-13","symbol":"SDZNY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1710302400000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SDZNY\",market:\"US\",,,undefined,":[{"executeDate":"2024-05-03","recordDate":"2024-05-06","paymentDate":"2024-05-07","value":0.4983609,"currency":"USD"},{"executeDate":"2025-04-22","recordDate":"2025-04-22","paymentDate":"2025-04-23","value":0.67446,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SDZNY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.5,"hold":0.2143,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":14,"updateTime":1746244800000}}}